Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer—Results of a nationwide population-based study
- 1 December 2016
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 69, 1-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer—Does pT0 Predict Better Survival than pTa/Tis/T1?Journal of Urology, 2016
- Perioperative treatment and radical cystectomy for bladder cancer – a population based trend analysis of 10,338 patients in the NetherlandsEuropean Journal of Cancer, 2016
- A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical CystectomyJournal of Urology, 2016
- EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 GuidelinesEuropean Urology, 2014
- Induction Chemotherapy Followed by Surgery in Node Positive Bladder CancerUrology, 2014
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 TrialJournal of Clinical Oncology, 2011
- Induction chemotherapy for unresectable urothelial carcinoma of the bladderBJU International, 2010
- A New Multimodality Technique Accurately Maps the Primary Lymphatic Landing Sites of the BladderEuropean Urology, 2010
- Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient DataEuropean Urology, 2005
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003